日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hsa_circ_0059511 promote glioma cell proliferation and migration through hsa-miR-194-5p/HBEGF axis.

Hsa_circ_0059511 通过 hsa-miR-194-5p/HBEGF 轴促进胶质瘤细胞增殖和迁移

Jing Yajun, Shang-Guan Huang-Cheng, Cai Jiawei, Su Jinye, Huang Wei, He Qiu, Chen Xiaoyong, Kang Dezhi, Wu Zanyi

Higher levels of plasma phosphatidylcholine (17:0_18:1) raise the risk of developing Parkinson's disease

血浆磷脂酰胆碱(17:0-18:1)水平升高会增加患帕金森病的风险。

Su, Daoqing; Jing, Yajun; Su, Jinye; Zhu, Honglin; Chen, Yiming; He, Qiu; Wang, Dengliang; Kang, Dezhi; Lin, Yuanxiang

Development and validation of a prognostic nomogram for overall survival in individuals with malignant meningiomas: a population-based study

建立和验证用于预测恶性脑膜瘤患者总生存期的预后列线图:一项基于人群的研究

Ge, Hongliang; Jing, Yajun; Su, Jinye; He, Qiu; Wang, Dengliang; Cai, Jiawei; Wu, Zanyi; Kang, Dezhi

Association of Hsa_circ_0059511 with the sensitivity of the temozolomide chemotherapeutic treatment in human glioma cells.

Hsa_circ_0059511 与人类胶质瘤细胞对替莫唑胺化疗的敏感性相关

Chen Yiming, Cheng Pingxin, Huang Wei, Jing Yajun, Su Jinye, Wu Zanyi, Cai Jiawei

The protective effect of higher serum TAG (51:4) levels against Parkinson's disease

血清TAG(51:4)水平升高对帕金森病具有保护作用

Jing, Yajun; Su, Jinye; Zhu, Honglin; Chen, Yiming; Shukla, Surmai; Yu, Lianghong; Wang, Dengliang; Kang, Dezhi